Thank you so much for the question.
As of April, 4,500 patients in Quebec have received Paxlovid, and about 70% of those prescriptions have been written by pharmacists. A key enabler, I would say, has been virtual prescribing, so that symptomatic patients don't show up at the pharmacy door. The Quebec government has recognized the complexity and the time needed to ensure safe prescribing, and providing pharmacies with the appropriate funding and resources to do this has been instrumental in increasing that access.
Patients are able to have home deliveries for the rapid antigen test. They're able to confirm their diagnosis. They're able to consult with their pharmacist over the telephone. It's a very well-thought-out model, and it's working. We're starting to see that trend in Alberta, Newfoundland and Labrador and Saskatchewan, and as these provinces work within the regulatory relations to enable them to remove these barriers, I think we're going to really be able to improve access. The impact that will have on COVID and getting rid of it and getting us back to normal, I think, will be significant.